novembre 11, 2022

Laboratoires SMB’s cholecalciferol product is ideal in prevention of the seasonal bronchiolitis epidemic

Currently, the bronchiolitis epidemic is globally accelerating and worsening. This common lung infection affects essentially young infants provoking coughs and difficulties in breathing and increases the risk of hospitalization in intensive units and/or the length of stay in hospitals and children.